Zhang Jia, Guo Yanyan, Ge Wanyu, Zhou Xia, Pan Minglin
Sir Run Run Hospital, Nanjing Medical University, Jiangsu, Nanjing 211100, P.R. China.
Department of Pharmacology, School of Basic Medical Science, Nanjing Medical University, Jiangsu, Nanjing 211166, P.R. China.
Exp Ther Med. 2019 Jul;18(1):621-629. doi: 10.3892/etm.2019.7609. Epub 2019 May 24.
Hyperglycemia in patients with diabetes induces vascular endothelial cell apoptosis and subsequent vasculopathy. The aim of the current study was to investigate the pathological mechanism of hyperglycemia-induced endothelial cell apoptosis and vasculopathy using human umbilical vein endothelial cells. As high glucose-induced apoptosis is caused by elevated mitochondrial permeability-mediated release of mitochondrial cytochrome c, the current study examined voltage-dependent anion channel (VDAC1), the controller of mitochondrial permeability, and its regulators, hexokinase2 (HK2), Bcl-2 and Bax. The current study demonstrated that HK2 may be involved in high glucose-induced cell apoptosis, as HK2 overexpression partially reversed high glucose-induced downregulation of mitochondrial/cellular HK2 and Bcl-2 as well as upregulation of mitochondrial Bax. These results suggest that HK2 overexpression partially reversed the reduced binding of HK2 and Bcl-2 and the enhanced binding of Bax to VDAC1, which reduced the high mitochondrial permeability observed under high-glucose conditions. Furthermore, high glucose reduced HK2 transcription via down-regulation of the HK2 transcriptional factor, peroxisome proliferator activated receptor γ (PPARγ). Taken together, these results suggest that PPARγ/HK2 may be novel targets for the prevention of diabetic vasculopathy.
糖尿病患者的高血糖会诱导血管内皮细胞凋亡及随后的血管病变。本研究的目的是利用人脐静脉内皮细胞研究高血糖诱导内皮细胞凋亡和血管病变的病理机制。由于高糖诱导的细胞凋亡是由线粒体通透性升高介导的线粒体细胞色素c释放所致,本研究检测了线粒体通透性的调控因子电压依赖性阴离子通道(VDAC1)及其调节因子己糖激酶2(HK2)、Bcl-2和Bax。本研究表明,HK2可能参与高糖诱导的细胞凋亡,因为HK2过表达部分逆转了高糖诱导的线粒体/细胞HK2和Bcl-2的下调以及线粒体Bax的上调。这些结果表明,HK2过表达部分逆转了HK2与Bcl-2结合减少以及Bax与VDAC1结合增强的情况,这降低了在高糖条件下观察到的高线粒体通透性。此外,高糖通过下调HK2转录因子过氧化物酶体增殖物激活受体γ(PPARγ)来降低HK2转录。综上所述,这些结果表明PPARγ/HK2可能是预防糖尿病血管病变的新靶点。